Your browser doesn't support javascript.
loading
Outcomes up to age 36 months after congenital Zika virus infection-U.S. states.
Neelam, Varsha; Woodworth, Kate R; Chang, Daniel J; Roth, Nicole M; Reynolds, Megan R; Akosa, Amanda; Carr, Christopher P; Anderson, Kayla N; Mulkey, Sarah B; DeBiasi, Roberta L; Biddle, Cara; Lee, Ellen H; Elmore, Amanda L; Scotland, Sarah J; Sowunmi, Similoluwa; Longcore, Nicole D; Ahmed, Muhammad; Langlois, Peter H; Khuwaja, Salma; Browne, Shea Elizabeth; Lind, Leah; Shim, Kyoo; Gosciminski, Michael; Blumenfeld, Rachel; Khuntia, Shreya; Halai, Umme-Aiman; Locklear, Autumn; Chan, Mary; Willabus, Teri'; Tonzel, Julius; Marzec, Natalie S; Barreto, Nianest Alers; Sanchez, Connie; Fornoff, Jane; Hale, Shelby; Nance, Amy; Iguchi, Lisa; Adibhatla, Sowmya N; Potts, Emily; Schiffman, Elizabeth; Raman, Devin; McDonald, Morgan F; Stricklin, Brandi; Ludwig, Elizabeth; Denson, Lindsay; Contreras, Dianna; Romitti, Paul A; Ferrell, Emily; Marx, Meghan; Signs, Kimberly.
Afiliação
  • Neelam V; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA. pju4@cdc.gov.
  • Woodworth KR; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Chang DJ; Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA.
  • Roth NM; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Reynolds MR; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Akosa A; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Carr CP; Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA.
  • Anderson KN; Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Mulkey SB; Children's National Hospital, Washington, D. C., USA.
  • DeBiasi RL; The George Washington University School of Medicine and Health Sciences, Washington, D. C., USA.
  • Biddle C; Children's National Hospital, Washington, D. C., USA.
  • Lee EH; The George Washington University School of Medicine and Health Sciences, Washington, D. C., USA.
  • Elmore AL; Children's National Hospital, Washington, D. C., USA.
  • Scotland SJ; The George Washington University School of Medicine and Health Sciences, Washington, D. C., USA.
  • Sowunmi S; New York City Department of Health & Mental Hygiene, New York City, NY, USA.
  • Longcore ND; Florida Department of Health, Tampa, FL, USA.
  • Ahmed M; Massachusetts Department of Public Health, Boston, MA, USA.
  • Langlois PH; California Department of Public Health, Sacramento, CA, USA.
  • Khuwaja S; New York State Department of Health, Albany, NY, USA.
  • Browne SE; New Jersey Department of Health, Trenton, NJ, USA.
  • Lind L; Texas Department of State Health Services, Austin, TX, USA.
  • Shim K; Houston Health Department, Houston, TX, USA.
  • Gosciminski M; Virginia Department of Health, Richmond, VA, USA.
  • Blumenfeld R; Pennsylvania Department of Health, Pittsburgh, PA, USA.
  • Khuntia S; Dallas County Health and Human Services, Dallas, TX, USA.
  • Halai UA; Rhode Island Department of Health, Providence, RI, USA.
  • Locklear A; Philadelphia Department of Public Health, Philadelphia, PA, USA.
  • Chan M; District of Columbia Department of Health, Washington, D. C, USA.
  • Willabus T; Los Angeles County Department of Public Health, Los Angeles, CA, USA.
  • Tonzel J; North Carolina Department of Health and Human Services, Chapel Hill, NC, USA.
  • Marzec NS; Washington State Department of Health, Seattle, WA, USA.
  • Barreto NA; Georgia Department of Public Health, Atlanta, GA, USA.
  • Sanchez C; Louisiana Department of Health, New Orleans, LA, USA.
  • Fornoff J; Colorado Department of Public Health and Environment, Denver, CO, USA.
  • Hale S; Hawaii Department of Health, Honolulu, HI, USA.
  • Nance A; Hidalgo County Health & Human Services Department, Hidalgo, TX, USA.
  • Iguchi L; Illinois Department of Public Health, Springfield, IL, USA.
  • Adibhatla SN; Ohio Department of Health, Columbus, OH, USA.
  • Potts E; Utah Department of Health and Human Services, Salt Lake City, UT, USA.
  • Schiffman E; Oregon Health Authority, Salem, OR, USA.
  • Raman D; Wisconsin Department of Health Services, Madison, WI, USA.
  • McDonald MF; Indiana Department of Health, Indianapolis, IN, USA.
  • Stricklin B; Minnesota Department of Health, Minneapolis, MN, USA.
  • Ludwig E; Southern Nevada Health District, Las Vegas, NV, USA.
  • Denson L; Tennessee Department of Health, Nashville, TN, USA.
  • Contreras D; Arkansas Department of Health, Little Rock, AR, USA.
  • Romitti PA; Nebraska Department of Health and Human Services, Lincoln, NE, USA.
  • Ferrell E; Oklahoma State Department of Health, Oklahoma City, OK, USA.
  • Marx M; Arizona Department of Health Services, Tempe, AZ, USA.
  • Signs K; University of Iowa College of Public Health, Iowa City, IA, USA.
Pediatr Res ; 95(2): 558-565, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37658124
ABSTRACT

BACKGROUND:

To characterize neurodevelopmental abnormalities in children up to 36 months of age with congenital Zika virus exposure.

METHODS:

From the U.S. Zika Pregnancy and Infant Registry, a national surveillance system to monitor pregnancies with laboratory evidence of Zika virus infection, pregnancy outcomes and presence of Zika associated birth defects (ZBD) were reported among infants with available information. Neurologic sequelae and developmental delay were reported among children with ≥1 follow-up exam after 14 days of age or with ≥1 visit with development reported, respectively.

RESULTS:

Among 2248 infants, 10.1% were born preterm, and 10.5% were small-for-gestational age. Overall, 122 (5.4%) had any ZBD; 91.8% of infants had brain abnormalities or microcephaly, 23.0% had eye abnormalities, and 14.8% had both. Of 1881 children ≥1 follow-up exam reported, neurologic sequelae were more common among children with ZBD (44.6%) vs. without ZBD (1.5%). Of children with ≥1 visit with development reported, 46.8% (51/109) of children with ZBD and 7.4% (129/1739) of children without ZBD had confirmed or possible developmental delay.

CONCLUSION:

Understanding the prevalence of developmental delays and healthcare needs of children with congenital Zika virus exposure can inform health systems and planning to ensure services are available for affected families. IMPACT We characterize pregnancy and infant outcomes and describe neurodevelopmental abnormalities up to 36 months of age by presence of Zika associated birth defects (ZBD). Neurologic sequelae and developmental delays were common among children with ZBD. Children with ZBD had increased frequency of neurologic sequelae and developmental delay compared to children without ZBD. Longitudinal follow-up of infants with Zika virus exposure in utero is important to characterize neurodevelopmental delay not apparent in early infancy, but logistically challenging in surveillance models.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / Transtornos do Neurodesenvolvimento / Zika virus / Infecção por Zika virus / Microcefalia Tipo de estudo: Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Revista: Pediatr Res Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / Transtornos do Neurodesenvolvimento / Zika virus / Infecção por Zika virus / Microcefalia Tipo de estudo: Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Revista: Pediatr Res Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos